Eculizumab for drug-induced de novo posttransplantation thrombotic microangiopathy: A case report

Clinical Nephrology

Volumn 83, Issue 2, 2015, Pages 125-129

  Safa, Kassem ^a   Logan, Merranda S ^a   Batal, Ibrahim ^a   Gabardi, Steven ^a   Rennke, Helmut G ^a   Abdi, Reza ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Druginduced thrombotic microangiopathy; Eculizumab; Transplantation

Indexed keywords

BASILIXIMAB; BELATACEPT; CREATININE; ECULIZUMAB; HEMOGLOBIN; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; BLOOD PRESSURE; CASE REPORT; CREATININE BLOOD LEVEL; FOLLOW UP; HUMAN; HUMAN TISSUE; HYDRONEPHROSIS; HYPERTENSION; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOSUPPRESSIVE TREATMENT; MALE; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; ADVERSE EFFECTS; CHEMICALLY INDUCED; KIDNEY TRANSPLANTATION; PATHOLOGY; PROCEDURES; THROMBOTIC MICROANGIOPATHIES;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; TACROLIMUS; THROMBOTIC MICROANGIOPATHIES;

EID: 84902139084     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN108163     Document Type: Article

References (19)

1. Ruggenenti P, Noris M, Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int. 2001; 60: 831-846.
2. Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med. 2009; 361: 1676-1687.
3. Noris M, Remuzzi G. Thrombotic microangiopathy after kidney transplantation. Am J Transplant. 2010; 10: 1517-1523.
4. Gruppo RA, Rother RP. Eculizumab for congenital atypical hemolytic-uremic syndrome. N Engl J Med. 2009; 360: 544-546.
5. Chandran S, Baxter-Lowe L, Olson JL, Tomlanovich SJ, Webber A. Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation -a case report. Transplant Proc. 2011; 43: 2097-2101.
6. Wilson CH, Brown AL, White SA, Goodship TH, Sheerin NS, Manas DM. Successful treatment of de novo posttransplant thrombotic microangiopathy with eculizumab. Transplantation. 2011; 92: e42-e43.
7. Meehan SM, Kremer J, Ali FN, Curley J, Marino S, Chang A, Kadambi PV. Thrombotic microangiopathy and peritubular capillary C4d expression in renal allograft biopsies. Clin J Am Soc Nephrol. 2011; 6: 395-403.
8. Le Quintrec M, Lionet A, Kamar N, Karras A, Barbier S, Buchler M, Fakhouri F, Provost F, Fridman WH, Thervet E, Legendre C, Zuber J, Frémeaux-Bacchi V. Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation. Am J Transplant. 2008; 8: 1694-1701.
9. Ashman N, Chapagain A, Dobbie H, Raftery MJ, Sheaff MT, Yaqoob MM. Belatacept as maintenance immunosuppression for postrenal transplant de novo drug-induced thrombotic microangiopathy. Am J Transplant. 2009; 9: 424-427.
10. Satoskar AA, Pelletier R, Adams P, Nadasdy GM, Brodsky S, Pesavento T, Henry M, Nadasdy T. De novo thrombotic microangiopathy in renal allograft biopsies-role of antibody-mediated rejection. Am J Transplant. 2010; 10: 1804-1811.
11. Sarkodee-Adoo C, Sotirescu D, Sensenbrenner L, Rapoport AP, Cottler-Fox M, Tricot G, Ruehle K, Meisenberg B. Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A. Transfusion. 2003; 43: 78-84.
12. Boctor FN. Tacrolimus (FK506) associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in lung transplant salvage with a plasmapheresis and cyclosporin. Egypt J Immunol. 2006; 13: 95-99.
13. Ramasubbu K, Mullick T, Koo A, Hussein M, Henderson JM, Mullen KD, Avery RK. Thrombotic microangiopathy and cytomegalovirus in liver transplant recipients: a case-based review. Transpl Infect Dis. 2003; 5: 98-103.
14. Zoja C, Furci L, Ghilardi F, Zilio P, Benigni A, Remuzzi G. Cyclosporin-induced endothelial cell injury. Lab Invest. 1986; 55: 455-462.
15. Sahin G, Akay OM, Bal C, Yalcin AU, Gulbas Z. The effect of calcineurin inhibitors on endothelial and platelet function in renal transplant patients. Clin Nephrol. 2011; 76: 218-225.
16. Del Conde I, Crúz MA, Zhang H, López JA, Afshar-Kharghan V. Platelet activation leads to activation and propagation of the complement system. J Exp Med. 2005; 201: 871-879.
17. González-Roncero F, Suñer M, Bernal G, Cabello V, Toro M, Pereira P, Angel Gentil M. Eculizumab treatment of acute antibody-mediated rejection in renal transplantation: case reports. Transplant Proc. 2012; 44: 2690-2694.
18. Kojouri K, George JN. Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation. Curr Opin Oncol. 2007; 19: 148-154.
19. Siami K, Kojouri K, Swisher KK, Selby GB, George JN, Laszik ZG. Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study. Transplantation. 2008; 85: 22-28.